Chris Freeman - 15 Jun 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John Saia, as attorney-in-fact for Chris Freeman
Issuer symbol
GH
Transactions as of
15 Jun 2022
Transactions value $
-$64,853
Form type
4
Filing time
17 Jun 2022, 17:59:43 UTC
Previous filing
05 Aug 2021
Next filing
09 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +4.88K $0.00 4.88K 15 Jun 2022 Direct
transaction GH COMMON STOCK Tax liability -$64.9K -1.69K -34.6% $38.42 3.19K 15 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -4.88K -25% $0.00 14.6K 15 Jun 2022 COMMON STOCK 4.88K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit vests as to 25% of the shares subject to such award on June 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of June 15, 2022, during the three-year period thereafter.
F2 Not applicable to Restricted Stock Units